Internal Server Error

About IC1101 Capital

IC1101 Capital is a venture capital firm founded in 2015. It is primarily based out of Delhi, India. It primarily invests in United Kingdom based startups. Its investments are spread across a wide range of sectors from High Tech to Enterprise Applications and Retail. Overall, IC1101 Capital portfolio has seen 2 acquisitions, namely Cuckoo. IC1101 Capital has team of 2 people including 2 partners.
Key Metrics
Portfolio Count
Portfolio Locations
Portfolio Acquisitions

IC1101 Capital's List of Top Investments

IC1101 Capital has a portfolio of 20 companies. Their most notable investments include Cuckoo and IntelliTeq.Their portfolio spans across United Kingdom, United States, Australia and 6 more locations. They have invested in High Tech, Enterprise Applications, Retail and 18 other sectors. Here is the list of top investments by IC1101 Capital:
Provider of residential broadband internet services with fibre optic technology. The company offers options for streaming, online gaming, and working from home. It provides customers with equipment and applications for account management. The company facilitates switching from other providers. Security and privacy features are included with all plans.

Key facts about Cuckoo

Axela-Tech offers a cloud-based platform for locating and recovering unclaimed assets. The solution assist corporations to comply with regulatory challenges. It enables members to locate and claim entitlements across multiple financial sectors and products. The platform offers an interface for real-time searching of unclaimed financial entitlements.

Key facts about IntelliTeq

Emerald Health Pharmaceuticals (EHP) is a part of Emerald Health Sciences (EHS), focuses on discovering, developing and commercializing proprietary cannabinoid-derived medicines. It has two proprietary drugs in preclinical development. EHP-101 is derived from cannabidiol (CBD) for the treatment of multiple sclerosis & scleroderma and EHP-102 is derived from cannabigerol (CBG) is for the treatment of Huntington’s and Parkinson’s disease. The postulated MOA of these drugs is dual PPARγ and CB2 agonist. EHP-1 got an orphan drug designation for systemic scleroderma by US FDA, recently.

Key facts about Emerald Health Pharma

  • Founded Year: 2017
  • Location: San Diego (United States)
  • Stage: Series A
  • Total Funding till date: $52M
  • Employee Count: 20 as on Mar 31, 2026
  • Investors: Ray Family and IC1101 Capital
  • Latest Funding Round: Series A, Apr 19, 2021, $*****
  • Highlight: Editors' Pick
Digitzs is a white label payment gateway, supporting payments in US dollars. It charges a flat fee of 2.9% + $0.3 per transaction. It offers its solutions to payment gateways which then offer to their merchants.

Key facts about Digitzs

HausMe is a manufacturer of prefabricated modular homes. The company develops energy-efficient smart homes with models such as mOne, mTwo, and mFour. It develops integrated intelligent smart homes.

Key facts about haus.me

Acquired companies in IC1101 Capital's Portfolio

2 companies from IC1101 Capital's portfolio have been acquired. The most recent acquisition was Cuckoo in Sep 2022 by Giganet for $*****.
Here are IC1101 Capital's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Sep 05, 2022
-
-
8320
May 05, 2021
-
-
7758

Team profile of IC1101 Capital

IC1101 Capital has a team of 2 members including 2 Partners located in United Arab Emirates. IC1101 Capital's team does not sit on the board of any company as of now.

FAQs about IC1101 Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford